ARTICLE SUMMARY:
NASS 2024 showcased a healthy spine industry, but a stressed-out surgical profession; VCs remain cautious about digital health investments despite evidence of a market rebound; Flow Medical's new catheter-delivered approach to treat pulmonary embolisms; and a look at some of the emerging innovators in heart failure. Plus profiles of DiaMonTech and Front Line Medical.
